Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Revance Therapeutics
(NQ:
RVNC
)
2.910
UNCHANGED
Streaming Delayed Price
Updated: 4:00 PM EDT, Jun 4, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Revance Therapeutics
< Previous
1
2
3
4
5
6
7
8
9
Next >
REVANCE THERAPEUTICS SHAREHOLDER NOTICE
December 02, 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Revance Therapeutics To Contact Him Directly To Discuss Their Options
Via
NewMediaWire
Exposures
Product Safety
REVANCE THERAPEUTICS SHAREHOLDER ALERT
December 01, 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Revance Therapeutics To Contact Him Directly To Discuss Their Options
Via
NewMediaWire
Exposures
Product Safety
REVANCE THERAPEUTICS INVESTOR ALERT
November 30, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
REVANCE THERAPEUTICS INVESTOR ALERT
November 28, 2021
Via
NewMediaWire
Exposures
Product Safety
REVANCE THERAPEUTICS UPDATE
November 27, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
REVANCE THERAPEUTICS SHAREHOLDER NOTICE
November 25, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
REVANCE THERAPEUTICS SHAREHOLDER ALERT
November 24, 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Revance Therapeutics To Contact Him Directly To Discuss Their Options
Via
NewMediaWire
Exposures
Product Safety
REVANCE THERAPEUTICS INVESTOR ALERT
November 23, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
REVANCE THERAPEUTICS INVESTOR ALERT
November 20, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
Revance to Present Clinical Data on DaxibotulinumtoxinA for Injection and Hyaluronic Acid Filler Injection Technique at the 2021 American Society for Dermatologic Surgery (ASDS) Virtual Annual Meeting
November 19, 2021
From
Revance Therapeutics, Inc.
Via
Business Wire
REVANCE THERAPEUTICS INVESTOR ALERT
November 19, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
Revance to Participate in the Piper Sandler 33rd Annual Virtual Healthcare Conference
November 18, 2021
From
Revance Therapeutics, Inc.
Via
Business Wire
REVANCE ALERT: Bragar Eagel & Squire, P.C. is Investigating Revance Therapeutics, Inc. on Behalf of Revance Stockholders and Encourages Investors to Contact the Firm
November 17, 2021
From
Bragar Eagel & Squire, P.C.
Via
Business Wire
INVESTIGATION ALERT: The Schall Law Firm Announces it is Investigating Claims Against Revance Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
November 17, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
REVANCE THERAPEUTICS INVESTOR ALERT
November 16, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
REVANCE THERAPEUTICS UPDATE
November 14, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
REVANCE THERAPEUTICS UPDATE
November 12, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
REVANCE THERAPEUTICS UPDATE
November 11, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
REVANCE THERAPEUTICS SHAREHOLDER NOTICE
November 10, 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Revance Therapeutics To Contact Him Directly To Discuss Their Options
Via
NewMediaWire
Exposures
Product Safety
Revance to Participate in the Stifel 2021 Virtual Healthcare Conference
November 10, 2021
From
Revance Therapeutics, Inc.
Via
Business Wire
REVANCE THERAPEUTICS SHAREHOLDER ALERT
November 09, 2021
Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Revance Therapeutics To Contact Him Directly To Discuss Their Options
Via
NewMediaWire
Exposures
Product Safety
Revance Reports Third Quarter 2021 Financial Results, Provides Corporate Update
November 09, 2021
From
Revance Therapeutics, Inc.
Via
Business Wire
REVANCE THERAPEUTICS INVESTOR ALERT
November 08, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
REVANCE THERAPEUTICS SHAREHOLDER ALERT
November 07, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
REVANCE THERAPEUTICS INVESTOR ALERT
November 05, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
REVANCE THERAPEUTICS UPDATE
November 04, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
REVANCE THERAPEUTICS SHAREHOLDER NOTICE
November 03, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Revance Therapeutics, Inc. and Encourages Investors with Losses to Contact the Firm
November 03, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Topics
Lawsuit
Exposures
Financial
Legal
Product Safety
REVANCE THERAPEUTICS SHAREHOLDER ALERT
November 02, 2021
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.
Via
NewMediaWire
Exposures
Product Safety
Revance to Release Third Quarter 2021 Financial Results on Tuesday, November 9, 2021
November 02, 2021
From
Revance Therapeutics, Inc.
Via
Business Wire
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.